Lars Weidolf
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Drug Transport and Resistance Mechanisms, Drug-Induced Hepatotoxicity and Protection, Computational Drug Discovery Methods
Most-Cited Works
- → COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES(2004)637 cited
- → Use of Radiolabeled Compounds in Drug Metabolism and Pharmacokinetic Studies(2012)286 cited
- → Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes(2000)273 cited
- → Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole(2001)238 cited
- → In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs(2012)212 cited
- → Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions(2003)206 cited
- → State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications(2007)140 cited
- → Mimicry of phase I drug metabolism – novel methods for metabolite characterization and synthesis(2007)140 cited
- → Determination of sulfonated azo dyes by liquid chromatography/atmospheric pressure ionization mass spectrometry(1987)133 cited
- → Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development(2010)102 cited